drug
RIFATER
Marketedupdated 3mo agoby Sanofi-Aventis US LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(25)
approval · 25
May 31, 1994
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Jul 8, 1994
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Apr 8, 1996
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Apr 12, 2000
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Oct 6, 2000
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Apr 28, 2005
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Dec 18, 2008
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Nov 12, 2010
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Feb 27, 2013
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Apr 24, 2017
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Jan 8, 2018
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Jan 23, 2019
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Feb 28, 2019
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Aug 27, 2019
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
May 12, 2020
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Jun 17, 2021
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Oct 21, 2021
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Jan 29, 2022
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Feb 10, 2023
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Aug 16, 2023
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Dec 8, 2023
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Oct 10, 2024
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Feb 5, 2025
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Oct 8, 2025
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Dec 5, 2025
approval
RIFATER (ISONIAZID) — FDA approval
RIFATER
→
Trials studying RIFATER
- phase2Tuberculosis Clinical Trials Consortium Study 35
- phase2Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- phase2Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- phase2Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
- phase1Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
- phase2PanACEA - STEP2C -01
- phase2Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- phase2A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that